Both offer meaningful weight loss in a daily tablet, though neither matches the weight-loss results of injectable Mounjaro
Three global clinical studies on IcoSema have been completed that show promise for the potential combination medication
Key takeaways MeAgain is the GLP-1 dose tracker app that keeps dose timing, shot or pill reminders, injection sites, dose changes, notes if a dose was late or missed, side effects, food, weight, and medication-level context on one timeline
Resistance training and muscle preservation During any weight loss, preserving lean muscle mass is essential
Methods: A systematic search was conducted in three electronic databases, namely Embase, PubMed, and the Cochrane Library, up until March 1, 2023, to identify randomized controlled trials (RCTs) comparing tirzepatide to either placebo or active hypoglycemic drugs in individuals with T2D and obesity